Atlas Trials

ANDES-AGI-1067 as a Novel Antidiabetic Agent Evaluation Study

Clinical trial NCT00525577 · UNKNOWN

Trial details

NCT number
NCT00525577
Sponsor
AtheroGenics
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Diabetes
Start date
2007-08-01
Primary completion
2008-06-01
Enrollment
1012

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.